Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
21
03
2021
accepted:
20
05
2021
entrez:
4
6
2021
pubmed:
5
6
2021
medline:
11
11
2021
Statut:
epublish
Résumé
Postoperative pancreatic fistula (POPF) with reported incidence rates up to 45% contributes substantially to overall morbidity. In this study, we conducted a retrospective evaluation of POPF along with its potential perioperative clinical risk factors and its effect on tumor recurrence. Clinical data on patients who had received pancreatoduodenectomy (PD), distal pancreatectomy (DP), or duodenum-preserving pancreatic head resection (DPPHR) were prospectively collected between 2007 and 2016. A Picrosirius red staining score was developed to enable morphological classification of the resection margin of the pancreatic stump. The primary end point was the development of major complications. The secondary end points were overall and recurrence-free survival. 340 patients underwent pancreatic resection including 222 (65.3%) PD, 87 (25.6%) DP, and 31 (9.1%) DPPHR. Postoperative major complications were observed in 74 patients (21.8%). In multivariable logistic regression analysis, POPF correlated with body mass index (BMI) (p = 0.025), prolonged stay in hospital (p<0.001), high Picrosirius red staining score (p = 0.049), and elevated postoperative levels of amylase or lipase in drain fluid (p≤0.001). Multivariable Cox regression analysis identified UICC stage (p<0.001), tumor differentiation (p<0.001), depth of invasion (p = 0.001), nodal invasion (p = 0.001), and the incidence of POPF grades B and C (p = 0.006) as independent prognostic markers of recurrence-free survival. Besides the known clinicopathological risk factors BMI and amylase in the drain fluid, the incidence of POPF correlates with high Picrosirius red staining score in the resection margins of the pancreatic stumps of curatively resected pancreatic ductal adenocarcinoma (PDAC). Furthermore, clinically relevant POPF seems to be a prognostic factor for tumor recurrence in PDAC.
Identifiants
pubmed: 34086792
doi: 10.1371/journal.pone.0252727
pii: PONE-D-21-09299
pmc: PMC8177431
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0252727Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Pancreatology. 2020 Oct;20(7):1558-1565
pubmed: 32972835
Br J Surg. 2005 Sep;92(9):1117-23
pubmed: 15931656
Medicine (Baltimore). 2017 May;96(19):e6858
pubmed: 28489778
Surgery. 2005 Jul;138(1):8-13
pubmed: 16003309
Ann Surg. 2006 Dec;244(6):931-7; discussion 937-9
pubmed: 17122618
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Surg Oncol. 2016 Feb;113(2):188-93
pubmed: 26678349
Br J Surg. 2012 Aug;99(8):1076-82
pubmed: 22556164
J Am Coll Surg. 2009 May;208(5):738-47; discussion 747-9
pubmed: 19476827
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Surgery. 2010 Jul;148(1):15-23
pubmed: 20138325
J Am Coll Surg. 2013 Oct;217(4):621-7
pubmed: 23810574
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Ann Surg. 1995 Oct;222(4):580-8; discussion 588-92
pubmed: 7574936
J Gastrointest Surg. 2021 Feb 11;:
pubmed: 33575903
Br J Surg. 2003 Feb;90(2):157-65
pubmed: 12555290
Br J Surg. 2000 Jul;87(7):883-9
pubmed: 10931023
Surgery. 2011 May;149(5):680-8
pubmed: 21316725
Pancreas. 1996 Aug;13(2):202-8
pubmed: 8829190
Surgery. 2017 Feb;161(2):365-372
pubmed: 27692778
Surgery. 2017 Mar;161(3):584-591
pubmed: 28040257
Ann Surg. 2014 Nov;260(5):857-63; discussion 863-4
pubmed: 25243549
Surgery. 1996 Mar;119(3):281-7
pubmed: 8619183
J Gastrointest Surg. 2004 Nov;8(7):766-72; discussion 772-4
pubmed: 15531229
Ann Surg. 2011 May;253(5):890-9
pubmed: 21394013
Surgery. 2017 May;161(5):1221-1234
pubmed: 28027816
JAMA. 2010 Sep 8;304(10):1073-81
pubmed: 20823433
Surgery. 2007 Nov;142(5):761-8
pubmed: 17981197
Surgery. 2003 Nov;134(5):766-71
pubmed: 14639354
Ann Surg. 1997 Nov;226(5):632-41
pubmed: 9389397
Ann Surg. 2015 Jun;261(6):1191-7
pubmed: 25371115
Ann Surg. 2007 Apr;245(4):573-82
pubmed: 17414606
Ann Surg. 2016 Mar;263(3):440-9
pubmed: 26135690
J Gastrointest Surg. 2008 Jan;12(1):51-6
pubmed: 17955317
Ann Surg. 2003 Jul;238(1):103-10
pubmed: 12832972
J Gastrointest Surg. 2014 Jan;18(1):172-79; discussion 179-80
pubmed: 24002771
World J Gastrointest Surg. 2017 Dec 27;9(12):270-280
pubmed: 29359033
Surgery. 2007 Jul;142(1):20-5
pubmed: 17629996
HPB (Oxford). 2016 Aug;18(8):642-51
pubmed: 27485058
Ann Surg. 2019 May;269(5):937-943
pubmed: 29240007
Biomed Res Int. 2014;2014:641239
pubmed: 24900974
Ann Surg. 2000 Sep;232(3):419-29
pubmed: 10973392
Clin Radiol. 2016 Oct;71(10):986-92
pubmed: 27426676
Ann Surg. 2012 Jul;256(1):139-45
pubmed: 22609844
Ann Surg. 2019 Feb;269(2):337-343
pubmed: 28938266
Br J Surg. 2003 Feb;90(2):215-9
pubmed: 12555298
Radiology. 2016 Apr;279(1):140-50
pubmed: 26566228
J Am Coll Surg. 2007 Mar;204(3):356-64
pubmed: 17324768
Ann Surg Oncol. 2011 Aug;18(8):2329-37
pubmed: 21327822
Cancer Chemother Pharmacol. 2013 Feb;71(2):419-29
pubmed: 23178955
Pancreatology. 2020 Dec;20(8):1779-1785
pubmed: 33077382
Ann Surg Oncol. 2011 Aug;18(8):2126-35
pubmed: 21336514
J Am Coll Surg. 2013 Jan;216(1):1-14
pubmed: 23122535
JAMA. 2007 Jan 17;297(3):267-77
pubmed: 17227978
Histochem J. 1979 Jul;11(4):447-55
pubmed: 91593
J Gastrointest Surg. 2006 Nov;10(9):1280-90; discussion 1290
pubmed: 17114014